Related Experiment Video
Updated: May 21, 2025

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
Published on: April 28, 2023
A single-cell transcriptomic atlas of immune cells in Wilson disease identifies copper-specific immune regulation
Shuya Wang1,2, Xianlei Sun3, Qingxuan Xin4
1Department of Blood Transfusion, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Insights
Wilson disease, caused by ATP7B gene mutations, disrupts immune homeostasis and hematopoietic development due to excess copper. This study maps the immune landscape in Wilson disease, revealing copper
Area of Science:
- * Genetics and Immunology
- * Cellular Metabolism
Background:
- * Wilson disease (WD) results from ATP7B gene mutations, causing abnormal copper metabolism and accumulation.
- * Understanding copper's impact on immune regulation and hematopoietic development is crucial for WD management and therapy.
- * Cuproptosis, a copper-dependent cell death, and its link to immune responses require further investigation.
Purpose of the Study:
- * To characterize the immune landscape in Wilson disease using single-cell RNA sequencing.
- * To investigate the effects of excess copper on immune cell function and metabolism.
- * To identify WD-specific immune signatures and explore the role of cuproptosis.
Main Methods:
- * Single-cell RNA sequencing (scRNA-seq) of peripheral blood mononuclear cells (PBMCs) from WD patients and healthy donors (HDs).
- * Immune cell subset clustering and assessment of cuproptosis-associated genes.
- * Differential gene expression analysis to identify WD-specific transcriptomic profiles.
Main Results:
- * Excess copper impairs immune homeostasis and hematopoietic development in WD patients.
- * A detailed immune landscape map for WD revealed metabolic reprogramming in immune cells, including glycolysis in CD14+ monocytes.
- * Antigen processing pathways and HLA molecule expression (HLA-I and HLA-II) are dysregulated; neurologic abnormality gene sets are altered in WD PBMCs.
- * Abnormal cuproptosis-associated gene expression observed in proliferating/malignant cells.
Conclusions:
- * Excess copper significantly disrupts immune homeostasis and hematopoietic development in Wilson disease.
- * scRNA-seq provides a comprehensive immune atlas of WD, highlighting metabolic shifts and pathway dysregulation.
- * Findings offer insights into WD pathogenesis and potential therapeutic targets, including cuproptosis in cancer treatment.
Abstract:
Wilson disease (WD) is caused by mutations of the copper-transporting gene, ATP7B, leading to abnormal copper metabolism. A better characterization of WD is essential in understanding the effects of excess copper and how it disrupts immune regulation and hematopoietic development. Furthermore, the exploration of the relationship between copper-mediated proliferation or cuproptosis and immune regulation is critical for developing new immune therapies. Therefore, we performed single-cell RNA sequencing (scRNA-seq) on peripheral blood mononuclear cells (PBMCs) to develop an atlas of the immune landscape. Cells were clustered into several immune subsets, and cuproptosis-associated genes were assessed. Differential expression analysis was performed to identify WD-specific signatures by comparing transcriptome profiles of patients with WD with HDs. Excess copper impaired immune homeostasis and hematopoietic development. Then, we developed a map of the immune landscape of patients with WD. Excess copper is involved in the metabolic reprogramming of immune cells, such as glycolysis in CD14+ monocytes. We found that the antigen processing-related pathway is dysregulated in immune cells of patients with WD. Our study revealed that abnormal copper concentration influences the expression of HLA-I and HLA-II molecules. It is noteworthy that a high concentration of intracellular copper differs significantly from the high concentration of extracellular copper. We have also identified a gene set of neurologic abnormalities, which were dysregulated in PBMCs of patients with WD. We also observed abnormal expression of cuproptosis-associated genes in proliferating or malignant cells, providing new insights into the application of cuproptosis in cancer treatment.
More Related Videos
11:04Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides
Published on: September 7, 2019
12:36Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry
Published on: June 26, 2018